What improvements could Sema4 make to its Expanded Carrier Screen to increase its detection rate for rare genetic disorders?

Introduction

To improve Sema4's Expanded Carrier Screen and increase its detection rate for rare genetic disorders, we need to analyze the current product, understand user needs, and explore innovative solutions. I'll outline a strategic approach to enhance this critical genetic testing tool.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking about the current detection capabilities. Could you share the current detection rate for rare genetic disorders and which specific disorders are currently covered?

Why it matters: Determines the baseline and helps identify gaps in coverage. Expected answer: Current detection rate is around 80% for 400+ rare genetic disorders. Impact on approach: Would focus on expanding the panel or improving detection methods for uncovered disorders.

• Considering user behavior, I'm curious about the typical user journey. How do patients and healthcare providers typically interact with the Expanded Carrier Screen results, and what follow-up processes are in place?

Why it matters: Helps identify potential pain points in result interpretation and follow-up care. Expected answer: Results are delivered to healthcare providers who then counsel patients; follow-up genetic counseling is recommended for positive results. Impact on approach: Might focus on improving result clarity or integrating better follow-up support.

• Thinking about external factors, I'm wondering about the competitive landscape. How does Sema4's detection rate compare to other leading genetic screening providers, and what unique features does our product offer?

Why it matters: Helps position the product in the market and identify areas for differentiation. Expected answer: Sema4 is in the top tier but not leading; unique features include comprehensive reporting and genetic counseling support. Impact on approach: Would focus on areas where we can leapfrog competitors or further enhance our unique offerings.

• Considering the product lifecycle, where is the Expanded Carrier Screen in its lifecycle, and what are the key metrics driving this improvement initiative?

Why it matters: Determines if we optimize for scale, feature expansion, or refinement. Expected answer: Mature product with steady growth; key metrics include detection rate, customer satisfaction, and market share. Impact on approach: Would focus on incremental improvements and maintaining market position.